JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB80588

Anti-NQO1 antibody [EPR3309]

4

(5 Reviews)

|

(214 Publications)

Anti-NQO1 antibody [EPR3309] (ab80588) is a rabbit monoclonal antibody detecting NQO1 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 130 publications
- Trusted since 2009

View Alternative Names

DIA4, NMOR1, NQO1, NAD(P)H dehydrogenase [quinone] 1, Azoreductase, DT-diaphorase, Menadione reductase, NAD(P)H:quinone oxidoreductase 1, Phylloquinone reductase, Quinone reductase 1, DTD, QR1

6 Images
Flow Cytometry (Intracellular) - Anti-NQO1 antibody [EPR3309] (AB80588)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-NQO1 antibody [EPR3309] (AB80588)

ab80588 staining NQO1in the human cell line MCF-7 (human breast carcinoma) by intracellular flow cytometry. Cells were fixed with 4% paraformaldehyde, permeabilized with 90% methanol and the sample was incubated with the primary antibody at a dilution of 1/20. A goat anti rabbit IgG (Alexa Fluorr® 488) at a dilution of 1/2000 was used as the secondary antibody.

Isoytype control : Rabbit monoclonal IgG (Black)

Unlabelled control : Cell without incubation with primary antibody and secondary antibody (Blue)

Immunocytochemistry/ Immunofluorescence - Anti-NQO1 antibody [EPR3309] (AB80588)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-NQO1 antibody [EPR3309] (AB80588)

Immunocytochemsitry/Immunofluorescence analysis of MCF-7 cells labelling NQO1 (green) with purified ab80588 at 1/80. Cells were fixed with 4% paraformaldehyde. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/200) was used as the secondary antibody. Counterstained with DAPI (blue).

Immunoprecipitation - Anti-NQO1 antibody [EPR3309] (AB80588)
  • IP

Unknown

Immunoprecipitation - Anti-NQO1 antibody [EPR3309] (AB80588)

ab80588 (purified) at 1/50 immunoprecipitating NQO1 in HeLa cell lysate (Lane 1). Lane 2 - PBS. For western blotting, a HRP-conjugated anti-rabbit IgG, specific to the non-reduced form of IgG was used as the secondary antibody (1/1500).

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Immunoprecipitation - Anti-NQO1 antibody [EPR3309] (ab80588)

Predicted band size: 31 kDa

Observed band size: 31 kDa

false

Western blot - Anti-NQO1 antibody [EPR3309] (AB80588)
  • WB

Lab

Western blot - Anti-NQO1 antibody [EPR3309] (AB80588)

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Western blot - Anti-NQO1 antibody [EPR3309] (ab80588) at 1/25000 dilution

Lane 1:

SH-SY5Y cell lysate at 20 µg

Lane 2:

Rat brain tissue lysate at 20 µg

Secondary

All lanes:

Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution

Predicted band size: 31 kDa

Observed band size: 31 kDa

false

Western blot - Anti-NQO1 antibody [EPR3309] (AB80588)
  • WB

Lab

Western blot - Anti-NQO1 antibody [EPR3309] (AB80588)

Lanes 1 - 6 : Merged signal (red and green). Green - ab80588 observed at 31 kDa. Red - loading control, ab9484, observed at 37 kDa.

ab80588 was shown to recognize NQO1 in wild-type HAP1 cells as signal was lost at the expected MW in NQO1 knockout cells. Wild-type and NQO1 knockout samples were subjected to SDS-PAGE. ab80588 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-NQO1 antibody [EPR3309] (ab80588) at 1 µg/mL

Lane 1:

Wild-type HAP1 whole cell lysate at 40 µg

Lane 2:

NQO1 knockout HAP1 whole cell lysate at 40 µg

Lane 3:

HepG2 whole cell lysate at 20 µg

Lane 4:

MEF1 whole cell lysate at 20 µg

Lane 5:

Human Kidney tissue lysate at 20 µg

Lane 6:

Mouse Kidney tissue lysate at 20 µg

Predicted band size: 31 kDa

false

Western blot - Anti-NQO1 antibody [EPR3309] (AB80588)
  • WB

Unknown

Western blot - Anti-NQO1 antibody [EPR3309] (AB80588)

All lanes:

Western blot - Anti-NQO1 antibody [EPR3309] (ab80588) at 1/50000 dilution

Lane 1:

MCF7 cell lysate at 10 µg

Lane 2:

HeLa cell lysate at 10 µg

Lane 3:

A549 cell lysate at 10 µg

Secondary

All lanes:

goat anti-rabbit HRP at 1/2000 dilution

Predicted band size: 31 kDa

Observed band size: 31 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR3309

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Rat, Human

Applications

WB, Flow Cyt (Intra), IP, ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30 - 1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/150000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/80", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/150000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/10000 - 1/150000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-NQO1 antibody [EPR3309] (ab80588) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.

What is the molecular weight of NQO1?
Anti-NQO1 [EPR3309] (ab80588) specifically detects a band for NQO1 (UniProt: P15559) at a molecular weight of 31kDa.

Trusted by the scientific community
Anti-NQO1 [EPR3309] (ab80588) was first used in a scientific publication in 2009 and has been cited over 130 times in peer-reviewed journals.

Reviewed by scientists
Anti-NQO1 [EPR3309] (ab80588) has over 5 independent reviews from customers.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-NQO1 antibody [EPR3309] (ab80588) has been confirmed by Western blot testing in NQO1 Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [EPR3309] also available for your convenience: ab80588, Alexa Fluor® 647 - ab196196, Alexa Fluor® 488 - ab196465, Carrier free - ab239896

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

NQO1 also known as NAD(P)H:quinone oxidoreductase 1 is a cytosolic enzyme involved in two-electron reduction processes. This protein plays a role in detoxification transforming quinones into less reactive and harmful hydroquinones. NQO1 has a molecular weight of approximately 31 kDa and is present in various tissues with high expression in the liver and lungs. Sometimes called DT-diaphorase it contributes to antioxidant protection within cells and assists in the stabilization of other proteins such as p53.
Biological function summary

NQO1 serves a protective function against oxidative stress by reducing quinones and preventing redox cycling that generates reactive oxygen species. Part of a critical network its function integrates with the cellular defense mechanism assisting in maintaining cellular homeostasis. NQO1 helps metabolize xenobiotics and is associated with phase II detoxification working alongside enzymes like glutathione S-transferases but is not part of a complex.

Pathways

NQO1 is an important component of the antioxidant defense pathway participating in the direct enzymatic reduction of quinones protecting cells from oxidative damage. It also interfaces with the KEAP1-NRF2 pathway where the NQO1 gene is regulated by the NRF2 transcription factor that upregulates its expression in response to oxidative stress. NQO1 interlinks with proteins such as p53 through pathways related to apoptotic regulation and cellular stress responses.

Mutations or altered expression of NQO1 have correlations with cancer development and progression notably in liver and lung cancers. This protein's stability influences cancer cell survival particularly under oxidative stress or chemotherapeutic treatments. NQO1 also exhibits links to Alzheimer's disease where its potential role in neuroprotection against oxidative damage draws investigation relating it to proteins like tau and amyloid-beta.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Flavin-containing quinone reductase that catalyzes two-electron reduction of quinones to hydroquinones using either NADH or NADPH as electron donors. In a ping-pong kinetic mechanism, the electrons are sequentially transferred from NAD(P)H to flavin cofactor and then from reduced flavin to the quinone, bypassing the formation of semiquinone and reactive oxygen species (By similarity) (PubMed : 8999809, PubMed : 9271353). Regulates cellular redox state primarily through quinone detoxification. Reduces components of plasma membrane redox system such as coenzyme Q and vitamin quinones, producing antioxidant hydroquinone forms. In the process may function as superoxide scavenger to prevent hydroquinone oxidation and facilitate excretion (PubMed : 15102952, PubMed : 8999809, PubMed : 9271353). Alternatively, can activate quinones and their derivatives by generating redox reactive hydroquinones with DNA cross-linking antitumor potential (PubMed : 8999809). Acts as a gatekeeper of the core 20S proteasome known to degrade proteins with unstructured regions. Upon oxidative stress, interacts with tumor suppressors TP53 and TP73 in a NADH-dependent way and inhibits their ubiquitin-independent degradation by the 20S proteasome (PubMed : 15687255, PubMed : 28291250).
See full target information NQO1

Publications (214)

Recent publications for all applications. Explore the full list and refine your search

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 56:647-655 PubMed40964101

2025

[Fufang Changtai Decoction Inhibites Colorectal Cancer Through Ferroptosis: Investigation of the Underlying Mechanism].

Applications

Unspecified application

Species

Unspecified reactive species

Jialin Gu,Lingchang Li,Ming Liu,Shan Deng,Jialin Yu,Jiege Huo,Yi Ji

Chembiochem : a European journal of chemical biology 26:e202500551 PubMed40931691

2025

Mitochondrial ClpX Inhibition Induces Ferroptosis and Blocks Pancreatic Cancer Cell Proliferation.

Applications

Unspecified application

Species

Unspecified reactive species

Pengyu Wang,Ranran Zhang,Yihui Pan,Wei Wu,Tao Zhang,Cai-Guang Yang

Mediators of inflammation 2025:4932970 PubMed40918406

2025

Electroacupuncture Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating the Esr1/TAK1-JNK/p38 Signaling Pathway in Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaofang Fan,Wei Guo,Xiaodan Yang,Hao Zhang,Bruno Fink,Lingyu Hu,Xiaoguang Wang

Autophagy reports 4:2551028 PubMed40910069

2025

Liver-specific loss of perturbs lipid metabolism and hepatocyte integrity.

Applications

Unspecified application

Species

Unspecified reactive species

Elodie Mailler,Asmita Singh,Michal Jarnik,Yan Li,Lynne Holtzclaw,Victoria Hoffmann,Sohtaro Mine,Paulina Stallcup,Laleh Ordoubadinia,Carlos M Guardia

International journal of molecular medicine 56: PubMed40709382

2025

Dulaglutide markedly prevents peritoneal fibrosis in a rodent model of chronic kidney disease: Insights into the pathogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Chih-Chao Yang,Ya Yue,Yi-Ting Wang,John Y Chiang,Ben-Chung Cheng,Tsuen-Wei Hsu,Yi-Ling Chen,Yi-Chen Li,Hon-Kan Yip

PloS one 20:e0325936 PubMed40601668

2025

PLZF promotes compensatory lung growth by increasing HPMEC proliferation and angiogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Jing Peng,Liang Ma,Zhonghui Wang,Yaxi Du,Qunfen Tao,Qiongchuan Wang,Li Zhao

World journal of diabetes 16:103685 PubMed40548264

2025

Erianin mitigates diabetic cardiomyopathy adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation.

Applications

Unspecified application

Species

Unspecified reactive species

Jia-Hui Chen,Xiao-Chun Dai,Zi-Jiao Quan,Xin-Yu Liu

Frontiers in cell and developmental biology 13:1598520 PubMed40530331

2025

Perillaldehyde synergizes with ferroptosis inducers to promote ferroptotic cell death in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Wang,Jin-Feng Cui,Jing Lv,Jia-Lin Song,Yang-Yang Lu,Xiao-Juan Huang,Zhong-Kun Lin,Si-Yi Zhang,Sha-Sha Wang,Wen-Sheng Qiu

Chinese medicine 20:83 PubMed40495179

2025

The gut microbiota-mediated ferroptosis pathway: a key mechanism of ginsenoside Rd against metabolism-associated fatty liver disease.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjing Liu,Xian Zhou,Liyu Xiao,Xiaolan Huang,Dennis Chang,Xiaomei Zhong,Minjie Zeng,Yanfang Xian,Yanfang Zheng,Wei Huang,Rui Huang,Mingqing Huang

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 29:547-557 PubMed40368848

2025

Amorfrutin A ameliorates cerebral ischemia/reperfsion injury and modulating Nrf2/HO-1 signaling pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Youxi Yang,Liying Shi,Xiaoting Xu,Bilan Luo,Xing Cui,Lei Tang,Jianta Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com